- Home
- Inflammatory bowel disease
Inflammatory bowel disease
Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.
What’s the difference between IBS and IBD?
These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
By the numbers: Understanding the toll of inflammatory bowel disease
For Colitis and Crohn’s Disease Awareness Week, learn about the challenges of this painful condition—and why Johnson & Johnson continues to seek new treatment options.
“My battle with IBD has fueled my passion for helping patients like me”
Sid Jain, a leader on the pharmaceutical R&D data science team at Johnson & Johnson, knows that new and better treatment options change lives. And being a Crohn’s disease patient himself has supercharged his mission to help revolutionize the research process.
5 things we now know about Crohn’s disease
Over the past few decades, advances in the study and treatment of this inflammatory bowel disease have rapidly accelerated. We spoke to the experts to learn the latest about managing Crohn’s disease—and what other potential breakthroughs are on the horizon.
“I’m driven by the knowledge of the difference we can make": Meet 10 scientists who really inspired us in 2019.
A groundbreaking trial for an HIV vaccine. New ways to help the body heal itself. Immunotherapy treatments for cancer. Behind medical advancements like these are the brilliant scientists who are relentlessly pushing their visions and research forward.
Have IBD? Read about the next frontier in disease research that taps into the microbiome
There are trillions of microorganisms living in your gut—and they might just be the key to helping treat diseases like Crohn’s and ulcerative colitis. Meet a researcher who spends her days exploring this microscopic world.
The facts about weight-loss surgery: Medical experts debunk 6 common myths
If getting healthy is one of your resolutions—and you’ve wondered about bariatric surgery—here are answers to some common questions, including what BMI you really need to have to qualify for the procedure and whether you can expect to gain any weight back.
“I am a triathlete with Crohn’s disease": Meet a man who’s been living and thriving with inflammatory bowel disease for half his life
Tackling a triathlon isn’t for the faint of heart. But Mark van Ooij, an Associate Scientific Director for Janssen Vaccines & Prevention B.V., is doing just that—and he’s taking what he’s learned from his disease to propel him forward.